Among all of the diverse epigenetic alterations contributing to prostate cancer progression, the loss of ten-eleven translocation (TET) enzymes plays a particularly important role. In normal cells, TET enzymes are master regulators of DNA demethylation. Reduced expression of TET enzymes in cancer results in increased methylation across the genome, affecting the expression of a wide variety of TET-target genes.